Jesper Elberling

Associate professor

University of Copenhagen

Denmark

Research Interests

Explore related searches

Professors in Immunology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jesper Elberling is an Associate Professor at the University of Copenhagen, Denmark. His research primarily focuses on atopic eczema and related conditions, including the prevalence and treatment of asthma in patients with atopic dermatitis. He has contributed to various studies on topics such as epidermal conditions and pruritus, as well as systematic reviews on treatment risks and patient quality of life in dermatological treatments.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (16)

Lauren Heathcote

King’s College London

UNITED KINGDOM

Jesper Elberling

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Baseline characteristics of atopic eczema patients enrolled in seven European registries united in the TREatment of ATopic eczema (TREAT) registry taskforce

Prevalence of Asthma and Asthma Severity Among Patients with Moderate–Severe Atopic Dermatitis Treated with Advanced Systemics

Primary aquagenic pruritus successfully treated by β-alanine: A case report.

Pitting Oedema in Morbihan Disease: An Overlooked Feature?

Gonococcal infection in a canal along the medial penile raphe

Food protein-induced enterocolitis syndrome

Isolated Periorbital Edema Linked to Artificial Nails: A Case of Allergic Contact Dermatitis

Worldwide prevalence of prurigo nodularis: A systematic review and meta‐analysis

Risk of infections during treatment with oral Janus kinase inhibitors in randomized placebo-controlled trials: A systematic review and meta-analysis

Improvement in quality of life in patients treated with lebrikizumab monotherapy is mediated by improvement in itch and sleep: Results from two Phase 3 trials in patients with moderate-to-severe atopic dermatitis

Mind and skin

Expression of CCR8 and CCX-CKR on Basophils in Chronic Urticaria Is Amplified by IgE-Mediated Activation.

Mast cell progenitors in chronic urticaria

A nationwide 104 weeks real‐world study of dupilumab in adults with atopic dermatitis: Ineffectiveness in head‐and‐neck dermatitis

Elevated, FcεRI-dependent MRGPRX2 expression on basophils in chronic urticaria.

Adverse reactions after oral provocation with aluminium in children with vaccination granulomas and aluminium contact allergy.

Short‐term real‐world experience with baricitinib treatment in Danish adults with moderate‐severe atopic dermatitis

Papain as a Potential New Experimental Model of Non-histaminergic Itch.

Severe and ChRonic Atopic dermatitis Treatment CoHort (SCRATCH): A Danish Real-world Evidence Atopic Dermatitis Treatment Registry.

Evaluation of itch and pain induced by bovine adrenal medulla (BAM)8-22, a new human model of non-histaminergic itch.

Collaborators (16)

Lauren Heathcote

Mette Søndergaard Deleuran

Carsten Bindslev‐Jensen

G. B. E. Jemec

Katya Rubia

DirkJan Hijnen

Emma Godfrey

Tomoki Arichi

Henrik Hedegaard Pliess Larsen

Ullrich Bartsch

Paola Dazzan

C. Vestergaard

Tobias Wood

Lars K. Poulsen

Silvia Lo Vecchio

Charlotte G. Mortz

Make your next move.